With no other option than to wait and see for post-thyroidectomy recurrent laryngeal nerve paralysis, nimodipine and/or steroid use may be viable options in the postoperative setting.
Practice Focus » Laryngology
Lipoinjection seems to be a safe, therapeutic option for patients with unilateral vocal fold paralysis, with efficacy lasting six months to one year.
Can a psychometrically reliable, valid patient-reported outcome measure (PROM) for unilateral vocal fold paralysis (UVFP)-related disability be developed that is appropriately rigorous for use in clinical trials? BOTTOM LINE The CoPE PROM could be a […]
An effective eluting endotracheal tube to modulate upper-airway bacterial infection during intubation could be deployed to help prevent subglottic stenosis.
The current literature unequivocally demonstrates that endoscopic percutaneous dilatational tracheostomy is at least as safe as open surgical tracheostomy.
Recurrent respiratory papillomatosis (RRP) is a potentially lethal disease caused by the human papillomavirus (HPV) and characterized by recurrent papillomas in the aerodigestive tract.
In May, the U.S. Food and Drug Administration approved dupilumab (Dupixent) as a treatment for eosinophilic esophagitis (EoE) in adults and pediatric patients 12 years and older weighing at least […]
A look at how procedural therapies compare to other established pharmacologic and nonpharmacologic methods in treating patients with neurogenic cough.
Most patients who receive vocal fold lipoaugmentation for glottal insufficiency experience a long-term benefit, although improvements in voice and swallowing taper over time.